Navigation Links
Scientist wins $3 million renewal of one of longest-running NIH grants to Scripps Research
Date:4/19/2012

LA JOLLA, CA April 19 The Scripps Research Institute has received a $3 million grant renewal from the National Institutes of Health (NIH) for support of scientist James Hoch's studies on bacterial signaling proteins. The four-year award will fund the ninth term of a grant that began in 1973making it one of the longest-running NIH grants awarded to Scripps Research.

"We started out with an important problem that no one knew much about or had good tools to study," said Hoch, a professor in Scripps Research's Department of Molecular and Experimental Medicine. "Our tools have become more sophisticated over the years, but our awareness of the true complexity of bacterial signaling has grown, too."

Hoch's research under the grant was initially aimed at understanding the signals that trigger "sporulation," the developmental process by which some bacteria suspend their normal growth and form tough, seed-like spores. One of the best-known spore-forming species, the infamous anthrax bacterium Bacillus anthracis, can survive this way indefinitely in soil or air; when its spores are inhaled or otherwise get into the body of a host, they switch back to growth-mode and cause frequently lethal infections.

Hoch and his lab at Scripps Research first identified the master gene that was required for sporulation in Bacillus subtilis, a closely related but safer-to-work-with species. In the mid-1980s, with the advent of gene cloning and DNA sequencing, the team purified the gene's product, a DNA-binding protein called Spo0A that serves as the bacterium's master trigger for sporulation.

Hoch's studies of Spo0A and its partner signaling proteins led to one of the earliest descriptions of a "two-component signaling pathway," a simple communication network that enables bacteria to sense and respond to specific stimuli. Such pathways start at the surface of bacterial cells, where sensor histidine kinase enzymes detect specific environmental factors and become activated; these activated enzymes in turn activate "response regulator" proteins inside the bacterial cell, which then switch on the appropriate bacterial gene responses.

"Bacteria use these signal transduction pathways to recognize and respond to the host tissue environment, the presence of other bacteria, and the presence of antibiotics or innate antibacterial peptides," Hoch said, "so the understanding of these interactions is essential to understanding bacterial infections."

In 1990, Hoch and his colleagues described a common biochemical mechanism used in these signaling pathways, a "phospho-relay" in which activating phosphate groups are passed from one signaling molecule to the next. A decade later, the researchers showed with crystal structure experiments precisely how these relay interactions occur. In 2009, in collaboration with physicist Terence Hwa at the University of California, San Diego, they developed a new cutting-edge computational techniqueundreamt of four decades agoto predict interaction sites on a large set of bacterial signaling proteins.

Hoch's major aim continues to be the identification and analysis of bacterial signaling interactionsbasic bacterial biology, in other words. But his findings have revealed innate signal-blocking enzymes and signal-transmitting protein interaction sites, both of which suggest strategies for translational medicine.

"Signal transduction pathways have not been widely exploited as antibiotic targets," he said, "yet by disrupting them one could stop the production of toxins and other virulence factors, and even interfere directly with essential bacterial functions."


'/>"/>

Contact: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute
Source:Eurekalert  

Related biology news :

1. Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells
2. Scientist plans to test for blood pressure genes affected by age
3. Scientists identify novel inhibitor of human microRNA
4. Argonne scientists peer into heart of compound that may detect chemical, biological weapons
5. MU scientists go green with gold, distribute environmentally friendly nanoparticles
6. Scientists identify gene that may contribute to improved rice yield
7. Scientists discover why a mothers high-fat diet contributes to obesity in her children
8. MU scientists see how HIV matures into an infection
9. Earth scientists keep an eye on Texas
10. Thinking it through: Scientists call for policy to guide biofuels industry toward sustainability
11. Scientists identify a molecule that coordinates the movement of cells
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientist wins $3 million renewal of one of longest-running NIH grants to Scripps Research
(Date:12/2/2016)... , December 1, 2016 ... type (Fingerprint, Voice), Future Technology (Iris Recognition System), ... Region - Global Forecast to 2021", published by ... 442.7 Million in 2016, and is projected to ... a CAGR of 14.06%.      (Logo: ...
(Date:11/30/2016)... and WARSAW, Poland , Nov. 30, 2016 Not many ... of the most crucial aspects of recovery so we need to do it well. ... risks, including heart problems, high blood pressure, stroke, diabetes, and even cancer. ... and find a Christmas present that could help them to manage their sleep quality? ... ...
(Date:11/29/2016)... BioDirection, a privately held medical device company ... detection of concussion and other traumatic brain injury (TBI), ... meeting with the U.S. Food and Drug Administration (FDA) ... During the meeting company representatives reviewed plans for clinical ... commencement of a planned pilot trial. ...
Breaking Biology News(10 mins):
(Date:12/7/2016)... , December 8, 2016 The report "Acrylic Processing Aid Market by ... Packaging, Automotive, Consumer Goods) - Global Forecast to 2026", published by MarketsandMarkets, the ... reach USD 1,173.6 Million by 2026, registering an of CAGR of 6.2% between ... ... MarketsandMarkets Logo ...
(Date:12/7/2016)... ANN ARBOR, Mich. , Dec. 7, ... developing breakthrough immune modulatory medicines, announced today the initiation ... lead therapeutic candidate, LYC-30937- E nteric C oated, ... skin disease that is estimated to affect as many ... , with approximately 1.5 - 3 million cases ...
(Date:12/7/2016)... ... December 07, 2016 , ... JULABO USA is ... cart. The new website has been designed to provide the best user-friendly experience ... to access detailed product information, read educational industry content as well as share ...
(Date:12/6/2016)... Dec. 6, 2016 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") ... the fourth quarter and fiscal year ended September 30, 2016. ... , , ... life sciences and diagnostics company that develops and commercializes proprietary technologies ... Achieved revenues of $1.4 million more than tripling ...
Breaking Biology Technology: